|
|
|
Volumn 118, Issue 1223, 2005, Pages
|
|
Non ST-elevation myocardial infarction: New Zealand management guidelines.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BIOLOGICAL MARKER;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NATRIURETIC FACTOR;
TROPONIN;
ANALGESIA;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLOOD;
CARDIOLOGY;
ELECTROCARDIOGRAPHY;
HEART INFARCTION;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
INFLAMMATION;
METABOLISM;
METHODOLOGY;
NEW ZEALAND;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
STANDARD;
ADRENERGIC BETA-ANTAGONISTS;
ANALGESIA;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BIOLOGICAL MARKERS;
CALCIUM CHANNEL BLOCKERS;
CARDIOLOGY;
CORONARY ANGIOGRAPHY;
ELECTROCARDIOGRAPHY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INFLAMMATION;
MYOCARDIAL INFARCTION;
MYOCARDIAL REVASCULARIZATION;
NATRIURETIC PEPTIDES;
NEW ZEALAND;
PLATELET AGGREGATION INHIBITORS;
RISK ASSESSMENT;
TROPONIN;
|
|
EID: 84921707198
PISSN: None
EISSN: 11758716
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|